Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
Condition:   Soft Tissue Sarcoma of the Extremities Intervention:   Sponsor:   Royal Marsden NHS Foundation Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials

Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Conditions:   Soft Tissue Sarcoma Adult;   Angiosarcoma;   Undifferentiated Pleomorphic Sarcoma Interventions:   Drug: Propranolol;   Drug: Pembrolizumab Sponsors:   Niels Junker;   Aarhus University Hospital;   Oslo University Hospital;   Karolinska University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials